Gilead Sciences Inc.

Public Company, Headquarters Location
333 Lakeside Dr., Foster City, CA 94404-1147, United States
(800)445-3235, (650)574-3000, (650)578-9264 fax, http://www.gilead.com

Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Founded by Michael Riordan, M.D. in 1987, Gilead Sciences incorporated in Delaware in 1987 and went public on the NASDAQ in 1992. Gilead is a biotechnology company specializing in developing drugs that treat antiviral diseases immunodeficiency virus (HIV), a virus that causes acquired immune deficiency syndrome (AIDS). The company also develops biopharmaceutical, commercializes innovative therapeutics in areas of unmet medical need through treatments for the HIV, and AIDS related infections such as Vistide, used to treat eye infections, and Viread, as an HIV treatment. Gilead has biotech balms for infectious diseases, including hepatitis and outside of the infectious disease, offers a treatment for pulmonary arterial hypertension (PAH), or high pulmonary blood pressure. The company promotes products through direct field contact with physicians, hospitals, clinics and other healthcare providers. Headquartered in Foster City, California, the company has operations in U.S. and international markets in Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, the Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, Turkey and the United Kingdom. Other subsidiaries maintained by the company include Triangle Pharmaceuticals, Inc., which offers a drug Tamiflu, to treat the flu and a drug to treat fungal infections, which is under the name AmBisome.Manufacturing: Biopharmaceuticals company developing anti-infectives, including antiviral, antibacterial and antifungals.